|
| | Publication Year | Title | Author(s) |
| 301 | 25-Aug-2022 | Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort study. | Patwala, Kurvi; Prince, David Stephen; Celermajer, Yael; Alam, Waafiqa; Paul, Eldho; Strasser, Simone Irene; McCaughan, Geoffrey William; Gow, Paul J ; Sood, Siddharth ; Murphy, Elise; Roberts, Stuart; Freeman, Elliot; Stratton, Elizabeth; Davison, Scott Anthony; Levy, Miriam Tania; Clark-Dickson, McCawley; Nguyen, Vi; Bell, Sally; Nicoll, Amanda; Bloom, Ashley; Lee, Alice Unah; Ryan, Marno; Howell, Jessica; Valaydon, Zina; Mack, Alexandra; Liu, Ken; Dev, Anouk |
| 302 | 11-Apr-2020 | Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel Disease | Peverelle, Matthew R ; Mills, Chris; Testro, Adam G ; Gow, Paul J ; De Cruz, Peter P |
| 303 | 20-Feb-2020 | Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel Disease. | Peverelle, Matthew R ; Mills, Christopher D; Testro, Adam G ; Gow, Paul J ; De Cruz, Peter P |
| 4 | 11-Apr-2020 | Letter to the Editor: Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial. | Gilmore, Robert B ; Choy, Matthew C ; Li Wai Suen, Christopher F D; De Cruz, Peter P |
| 5 | May-2020 | Letter to the Editor: Diagnosis of Cirrhotic Cardiomyopathy: The Role of an Impaired Cardiac Reserve. | Koshy, Anoop N ; Farouque, Omar ; Calafiore, Paul ; Gow, Paul J |
| 6 | May-2020 | Letter to the Editor: Moderate Alcohol Use in Fatty Liver Disease: Don't Throw the Cabernet Out With the Bathwater. | Gow, Paul J ; Testro, Adam G ; Hey, Penelope ; Sinclair, Marie |
| 7 | 2022 | Letter to the Editor: Rethinking public health measures to reduce liver injury from therapeutic acetaminophen ingestion. | Hey, Penelope ; Gow, Paul J |
| 8 | Oct-2024 | Letter: Association between terlipressin and multi-drug-resistant organism rectal colonisation. | Tan, Katrina; Jahanabadi, Hossein ; Pandey, Dinesh; Sinclair, Marie ; Majumdar, Avik; Trubiano, Jason ; Kwong, Jason C ; Testro, Adam G ; Smibert, Olivia C |
| 9 | Aug-2020 | Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail. | Srinivasan, Ashish ; De Cruz, Peter P ; van Langenberg, Daniel R |
| 10 | Jan-2024 | Letter: Comparing first-line infliximab and vedolizumab for ulcerative colitis-it depends on how you use the drug. | Con, Danny; Srinivasan, Ashish |
| 11 | Apr-2017 | Letter: dose optimising infliximab in acute severe ulcerative colitis. | Choy, Matthew C ; De Cruz, Peter |
| 12 | Jun-2020 | Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis? | Li Wai Suen, Christopher F D; Choy, Matthew C ; De Cruz, Peter P |
| 13 | Mar-2020 | Letter: infliximab induction regimens in steroid-refractory acute severe colitis-a propensity score analysis. | Li Wai Suen, Christopher F D; Choy, Matthew C ; De Cruz, Peter P |
| 14 | Jul-2019 | Letter: mechanistic target of rapamycin inhibitors-do they impact on recurrence of hepatocellular carcinoma after liver transplantation? Authors' reply. | Grigg, Samuel E ; Sarri, Gino L; Gow, Paul J ; Yeomans, Neville D |
| 15 | Dec-2018 | Letter: the effect of sirolimus on recurrence and survival in liver transplant recipients with hepatocellular carcinoma. | Grigg, Samuel E ; Gow, Paul J ; Yeomans, Neville D |
| 16 | Jan-2021 | Letter: TIPSS is a promising therapy for sarcopenia in cirrhosis. | Hey, Penelope ; Sinclair, Marie ; Testro, Adam G ; Gow, Paul J |
| 17 | Aug-2020 | Letter: ustekinumab dose intensification for loss of response-should we re-induce before shortening the dose interval? | Srinivasan, Ashish ; De Cruz, Peter P ; van Langenberg, Daniel R |
| 18 | 1-Jun-1988 | Lisinopril pharmacokinetics in chronic renal failure. | Jackson, B ; Cubela, R B; Conway, Elizabeth L; Johnston, Colin I |
| 19 | 21-Dec-2023 | Liver decompensation after rapid weight loss from semaglutide in a patient with non-alcoholic steatohepatitis -associated cirrhosis. | Peverelle, Matthew R ; Ng, Jonathan; Peverelle, James; Hirsch, Ryan D; Testro, Adam G |
| 20 | Jan-2023 | Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort. | Clark, Paul J; Valery, Patricia C; Strasser, Simone I; Weltman, Martin; Thompson, Alexander J; Levy, Miriam; Leggett, Barbara; Zekry, Amany; Rong, Julian; Angus, Peter W ; George, Jacob; Bollipo, Steven; McGarity, Bruce; Sievert, William; Macquillan, Gerry; Tse, Edmund; Nicoll, Amanda; Wade, Amanda; Chu, Geoff; Harding, Damian; Cheng, Wendy; Farrell, Geoff; Roberts, Stuart K |
